Overview

Bioequivalence Study of DelanzoᵀᴹDR 60mg (Dexlansoprazole) Capsule With Dexilant® 60mg (Dexlansoprazole) Capsule in Healthy Pakistani Subjects.

Status:
Recruiting

Trial end date:
2021-11-25

Target enrollment:

Participant gender:

Summary

Single oral dose of study drug in two period(s) separated by a washout period of seven (07) days. Blood samples will be taken up to 24.0 hours post-dose.

Phase:

Phase 1

Details

Lead Sponsor:

University of Karachi

Collaborator:

SAMI Pharmaceutical, Karachi Pakistan

Treatments:

Dexlansoprazole
Lansoprazole